Funding Data Link References Status API Help
Page 1 of 1 results
Sort by: relevance publication year

TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer

Journal Article published 12 Sep 2018 in Clinical Cancer Research

Research funded by Stichting Tegen Kanker (C/2014/227) | Vlaamse Liga Tegen Kanker (00000000116000000206) | Cancerfonden (09-0677) | Radiumhemmets Forskningsfonder (163012) | Familjen Erling-Perssons Stiftelse (4-2689-2016) | Vetenskapsrådet (K2010-70X-20430-04-3) | Royal College of Surgeons of England (C19198) | Cancer Research UK (A1533)

Authors: Bram De Laere, Steffi Oeyen, Markus Mayrhofer, Tom Whitington, Pieter-Jan van Dam, Peter Van Oyen, Christophe Ghysel, Jozef Ampe, Piet Ost, Wim Demey, Lucien Hoekx, Dirk Schrijvers, Barbara Brouwers, Willem Lybaert, Els G. Everaert, Daan De Maeseneer, Michiel Strijbos, Alain Bols, Karen Fransis, Nick Beije, Inge E. de Kruijff, Valerie van Dam, Anja Brouwer, Dirk Goossens, Lien Heyrman, Gert G. Van den Eynden, Annemie Rutten, Jurgen Del Favero, Mattias Rantalainen, Prabhakar Rajan, Stefan Sleijfer, Anders Ullén, Jeffrey Yachnin, Henrik Grönberg, Steven J. Van Laere, Johan Lindberg, Luc Y. Dirix